Ductal carcinoma in situ is a precursor of breast cancer that is usually treated with surgery, radiation therapy, and ...

A study finds that a sensitive test detecting circulating tumour DNA (ctDNA) in early-stage lung cancer can predict relapse ...

FN Media Group News Commentary - The healthcare industry is rapidly integrating artificial intelligence (AI)-powered solutions in various verticals to achieve higher operational & clinical outcomes, ...

The healthcare industry is rapidly integrating artificial intelligence (AI)-powered solutions in various verticals to achieve higher operational & clinical outcomes, which is a key contributing factor ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Scientists looked at multiple techniques used to measure the modified viruses deployed in some gene therapy research and treatments. One technique, known as SEC-MALS, was the most precise and accurate ...

Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...

The care plans improved radiation therapy efficiency and lightened the ... release from the National Cancer Institute. Here are five notes on the study: Researchers from Houston-based University ...

My approach to talk therapy is based on identifying and integrating parts of the individual and their experiences to foster self-awareness, practical solutions and advance personal growth.

As a strengths-based therapist, I will help you through your journey with skills and changes that can improve your life. Life is a journey and sometimes there are bumps along the way. I believe ...

Japan’s pet cancer therapeutics sector surges forward, propelled by evolving diagnostic tools, innovative drug breakthroughs, ...

While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.